Agranulocytosis Associated With Use of Sulfamethoxazole/Trimethoprim in a Healthy Adult

David Bunch, Carolyn Brands, Diana R. Langworthy

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: A case of sulfamethoxazole/trimethoprim-induced agranulocytosis is reported. Summary: A 53-year-old healthy male presented to the emergency room with a fever of 102.7°F and was found to have a white blood cell (WBC) count of 0.6 × 103 cells/μL with an absolute neutrophil count (ANC) of 0.0 x 103 cells/μL. He had recently completed a 10-day course of sulfamethoxazole/trimethoprim for left lower extremity cellulitis. During admission, a bone marrow biopsy was performed which was not concerning for malignancy and no cause for the agranulocytosis other than the sulfamethoxazole/trimethoprim was identified. The agranulocytosis resolved after 6 days of hospitalization with a WBC count of 8.9 × 103 cells/μL and an ANC of 4.1 x 103cells/μL on the day of discharge. Conclusion: A 53-year-old male developed agranulocytosis after 10 days of sulfamethoxazole/trimethoprim therapy for the treatment of a skin and soft tissue infection. His neutropenia resolved after sulfamethoxazole/trimethoprim discontinuation.

Original languageEnglish (US)
Pages (from-to)229-233
Number of pages5
JournalJournal of Pharmacy Practice
Volume37
Issue number1
DOIs
StatePublished - Feb 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2022.

Keywords

  • agranulocytosis
  • neutropenia
  • sulfamethoxazole/trimethoprim

PubMed: MeSH publication types

  • Case Reports
  • Journal Article

Fingerprint

Dive into the research topics of 'Agranulocytosis Associated With Use of Sulfamethoxazole/Trimethoprim in a Healthy Adult'. Together they form a unique fingerprint.

Cite this